Skip to content

Lung Ultrasound to Detect Pulmonary Complications in Critically Ill Parturients

Lung Ultrasound to Detect Pulmonary Complications in Critically Ill Parturients in an Urban Low-Resource Setting (LUSIP) - an Observational Study in Sierra Leone

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03828630
Acronym
LUSIP
Enrollment
168
Registered
2019-02-04
Start date
2018-07-08
Completion date
2019-03-28
Last updated
2019-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Distress Syndrome, Lung Injury, Acute, Obstetric Complication, Pulmonary Disease

Brief summary

This study aims at describing the frequency, timing and type of pulmonary complications detected with lung ultrasound in critically-ill parturients in admitted to a high-dependency unit in Freetown, Sierra Leone.

Detailed description

Rationale: The three big 'killers' in parturients, peripartum hemorrhage, sepsis and pre-eclampsia all predispose to pulmonary complications. These complications affect management before, during and after the primary obstetric problem has been solved. A timely diagnosis and thorough follow-up of pulmonary complications may benefit parturients. Lung ultrasound (LUS) is a point-of-care imaging bedside tool increasingly used in the critical care setting that may prove useful in parturients. Objective: To describe frequency, timing and type of pulmonary complications detected with LUS in critically ill parturients in a high-dependency unit (HDU), and to determine the association with outcome. Hypotheses: Pulmonary complications detected by LUS are frequent in parturients admitted to a HDU in a resource-limited setting, and are associated with hospital mortality. Study design: A prospective observational study. Study population: Critically ill parturients admitted to the HDU of the Princess Christian Maternity Hospital (PCMH) in Freetown, Sierra Leone. Sample size: No formal sample size calculation is performed. Based on current rates of admissions to the HDU of the PCMH the investigators expect to perform LUS in at least 125 patients. Methods: A trained physician performs all 12-region LUS investigations. LUS is performed at admission, after 24 and 48 hours, and when a patient's respiratory condition deteriorates. LUS findings are reported using a standardized semi-quantitative visual LUS scoring method. Main study parameters/primary endpoints: The proportion of critically ill parturients admitted to the HDU of the PCMH with pulmonary complications detected by LUS, including interstitial syndrome, pulmonary consolidation, and pleural effusion.

Interventions

None listed

Sponsors

Mahidol Oxford Tropical Medicine Research Unit
CollaboratorOTHER
University of Sierra Leone
CollaboratorOTHER
Doctors with Africa - CUAMM
CollaboratorOTHER
University of Bari
CollaboratorOTHER
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Admitted to the HDU of the PCMH during the study period * Verbal informed consent of the patient or his/her formal representative

Exclusion criteria

* Lung ultrasound not feasible, e.g., due to electricity breakdown, or absence of the trained sonographer.

Design outcomes

Primary

MeasureTime frameDescription
Proportion of parturients with pulmonary complicationsFrom admission to 48 hours laterproportion of parturients with pulmonary complications detected by LUS during stay in the HDU.

Secondary

MeasureTime frameDescription
Description of lung ultrasound findingsFrom admission to 48 hours laterPrecise description of ultrasound findings (proportion of patients with a normal lung, interstitial syndrome, lung consolidation, pleural effusion)
Description of diagnoses made with lung ultrasoundFrom admission to 48 hours laterProportion of patients with a diagnosis of pneumonia, acute respiratory distress syndrome, fluid overload, no pulmonary complication.
Relative risk of death in patients with a pulmonary complicationOn the day of HDU discharge or death, whichever came first, assessed up to 12 weeks after enrollmentRisk of death in the group with pulmonary complication divided by the risk of death in parturients without a pulmonary complication

Countries

Sierra Leone

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026